IL6 and diabetes mellitus: One possible reason for this is that subjects with diabetes have a higher risk of uncontrolled inflammatory response, higher levels of tissue injury–related enzymes, a higher hypercoagulable state, and higher serum levels of inflammatory biomarkers, such as C-reactive protein, D-dimer, interleukin-6 (IL-6), serum ferritin, and coagulation index.